造血干细胞移植术后慢性肝脏移植物抗宿主病的危险因素

肝脏 ›› 2020, Vol. 25 ›› Issue (5): 501-504.

造血干细胞移植术后慢性肝脏移植物抗宿主病的危险因素

李静, 陈芳芳, 李雯彬, 张文杰

730000 兰州西北民族大学附属医院甘肃省第二人民医院中西医结合肝病临床医学中心

收稿日期:2019-11-18 发布日期:2020-06-08
通讯作者: 张文杰,Email:zhangwenjie718@163.com
基金资助:
甘肃省自然科学基金项目(17JR5RA052)

Study on risk factors of chronic liver graft-versus-host disease after hematopoietic stem cell transplantation

LI Jing, CHEN Fang-fang, LI Wen-bin, ZHANG Wen-jie

Second provincial people's Hospital.Lanzhou City, Gansu 730000, China

Received:2019-11-18 Published:2020-06-08
Contact: ZHANG Wen-jie, Email:zhangwenjie718@163.com

摘要/Abstract

摘要： 目的研究造血干细胞移植(HSCT)术后肝脏慢性移植物抗宿主病(cGVHD)的危险因素。方法回顾性分析2014年4月至2019年4月甘肃省第二人民医院收治的149例HSCT患者的一般资料,分析术后肝脏cGVHD发生情况,采用多因素logistic回归分析法分析HSCT术后并发肝脏cGVHD的独立影响因素。结果 149例HSCT患者中,患者术后发生肝脏cGVHD 40例。多因素logistic回归分析显示,GVHD预防方案中加用ATG(OR=0.235,95%CI=0.113～0.490)、早期出现aGVHD(OR=2.089,95%CI=1.020～4.279)是HSCT患者术后肝脏cGVHD的独立影响因素(P<0.05)。结论 HSCT术后肝脏cGVHD的发生与移植早期出现aGVHD有关,而早期GVHD预防方案中加用ATG能降低其发生率。

关键词: 造血干细胞移植, 肝脏, 慢性移植物抗宿主病, 危险因素

Abstract: Objective To study the risk factors of chronic graft-versus-host disease (cGVHD) in liver after hematopoietic stem cell transplantation (HSCT).Methods 149 patients with HSCT admitted to our hospital from April 2014 to April 2019 were enrolled in this study and retrospectively analyzed.General data of the patients were collected and postoperative liver cGVHD incidence was analyzed. Multivariate Logistic regression analysis was used to analyze the independent influencing factors of postoperative liver cGVHD complicated with HSCT. Results Among 149 patients with HSCT, 40 patients had postoperative liver cGVHD, accounting for 26.85%; Liver cGVHD did not occur in 109 patients, accounting for 73.15%.Multivariate logistic regression analysis showed that the use of ATG (OR=0.235, 95%CI=0.113～0.490) and early onset of aGVHD (OR=2.089, 95%CI=1.020～4.279) were independent influencing factors of liver cGVHD after HSCT (P<0.05).Conclusion The occurrence of hepatic cGVHD after HSCT is related to the occurrence of cGVHD in the early stage of transplantation, and the use of ATG in the early prevention of GVHD can reduce the incidence.

Key words: Hematopoietic stem cell transplantation, Liver, Chronicity graft-versus-host disease, Risk Factors

李静, 陈芳芳, 李雯彬, 张文杰. 造血干细胞移植术后慢性肝脏移植物抗宿主病的危险因素[J]. 肝脏, 2020, 25(5): 501-504.

LI Jing, CHEN Fang-fang, LI Wen-bin, ZHANG Wen-jie. Study on risk factors of chronic liver graft-versus-host disease after hematopoietic stem cell transplantation[J]. Chinese Hepatolgy, 2020, 25(5): 501-504.

参考文献

[1] 肖扬, 肖浩文. 非血缘造血干细胞移植现状、困难及处理策略. 实用医学杂志, 2016, 32:4-8.
[2] 蔺诗佳, 赵伟, 陈婷, 等. 二次移植治疗异基因造血干细胞移植后复发急性髓系白血病5例临床观察. 第三军医大学学报, 2019, 41:2301-2306.
[3] 高莉, 胡昳歆, 卢俊, 等. 造血干细胞移植对c-kit突变阳性儿童急性髓细胞白血病的疗效观察. 中国小儿血液与肿瘤杂志, 2019, 24:173-178.
[4] 张雪, 明雅南, 张岚. 诱导性多能干细胞的安全性及其在肝细胞再生方面的应用潜能. 肝脏, 2016, 21:404-407.
[5] 党四华, 刘芩, 仲照东, 等. Allo-HSCT后芦可替尼抗移植物抗宿主病与抗白血病复发的作用. 中华器官移植杂志, 2018, 39:333-337.
[6] 范祎, 李飞, 王秀丽, 等. 异基因造血干细胞移植后慢性移植物抗宿主病:移植前肺功能对肺部受累的预测作用. 中国血液流变学杂志, 2017, 27:241-246.
[7] King PD , Perry MC . Hepatotoxicity of chemotherapy. Oncologist, 2001, 6:162-176.
[8] Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant, 2005, 11:945-956.
[9] Zheng CC, Zhu XY, Tang BL, et al. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML. Bone Marrow Transplant., 2017, 52:88-94.
[10] 尹琎, 王春艳, 黄敏, 等. 髓系来源抑制细胞在预测allo-HSCT后急性移植物抗宿主病中的作用. 中华器官移植杂志, 2016, 37:267-274.
[11] 孙于谦, 黄晓军, 许兰平, 等. 霉酚酸酯预防疗程对单倍体相合造血干细胞移植急性移植物抗宿主病的影响. 中华血液学杂志, 2018, 39:286-291.
[12] 李晓莉, 姚遥, 杨冰玉, 等. Tim-3 mRNA在异基因造血干细胞移植后急性移植物抗宿主病中的作用. 中华血液学杂志, 2016, 37:469-473.
[13] 杨欢, 李志涛, 林韧, 等. 造血干细胞移植后硬皮病样慢性移植物抗宿主病的临床表现. 南方医科大学学报, 2016, 36:807-813.
[14] 王丽, 吴亚妹, 曹永彬,等. 采用改良FC/ATG预处理方案的单倍体相合及HLA全相合造血干细胞移植治疗重型再生障碍性贫血的临床疗效分析. 中国实验血液学杂志, 2016, 24:1817-1823.
[15] 鲍协炳, 朱倩, 仇惠英,等. 异基因造血干细胞移植后EBV感染临床危险因素分析. 中华血液学杂志, 2016, 37:138-143.
[16] 于迪, 韩雅慧, 扈臣媛, 等. 异基因造血干细胞移植后慢性肝脏移植物抗宿主病的危险因素及预后分析. 中国实验血液学杂志, 2018, 26:1174-1179.
[17] 崔思远, 赵小利, 陈颖莹, 等. 低剂量ATG用于父母HLA 10/10相合造血干细胞移植患者的临床分析. 临床血液学杂志, 2015, 28:576-579.
[18] 刘颖, 江明, 袁海龙, 等. 减低剂量预处理单倍型外周血造血干细胞移植治疗50岁以上恶性血液肿瘤患者的临床研究. 中华血液学杂志, 2019, 40:667-672.